|1.||Passirani, Catherine: 6 articles (01/2015 - 09/2008)|
|2.||Vessières, Anne: 4 articles (01/2015 - 09/2008)|
|3.||Benoit, Jean-Pierre: 4 articles (02/2012 - 09/2008)|
|4.||Vessieres, Anne: 3 articles (02/2012 - 01/2008)|
|5.||Huynh, Ngoc Trinh: 3 articles (02/2012 - 12/2011)|
|6.||Jaouen, Gérard: 3 articles (01/2010 - 01/2008)|
|7.||Clavreul, Anne: 2 articles (01/2015 - 02/2012)|
|8.||Menei, Philippe: 2 articles (01/2015 - 02/2012)|
|9.||Garcion, Emmanuel: 2 articles (02/2012 - 09/2008)|
|10.||Allard, Emilie: 2 articles (01/2010 - 09/2008)|
02/14/2012 - "This cytotoxic effect was validated in vivo after intratumoral injection of Fc-diOH-LNC-loaded MIAMI cells in a heterotopic U87MG glioma model in nude mice. "
02/14/2012 - "Furthermore, Fc-diOH-LNC-loaded MIAMI cells produced a cytotoxic effect on U87MG glioma cells in vitro. "
09/11/2009 - "Moreover, the cytostatic activity of Fc-diOH-LNCs is confirmed on an orthotopic glioma model since the difference in survival time between the infusion of 0.36 mg/rat Fc-diOH-LNCs and blank LNCs is statistically significant. "
01/01/2010 - "Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft."
09/10/2008 - "For the first time, Fc-diOH was tested on a 9L glioma model according to two encapsulation strategies: lipid nanocapsules (LNC) and swollen micelles. "
02/14/2012 - "Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma."
02/14/2012 - "The anti-tumour effect of ferrociphenol (FcdiOH)-loaded lipid nanocapsules (LNCs), with or without a DSPE-mPEG2000 coating, was evaluated on an orthotopic gliosarcoma model after administration by convection-enhanced delivery (CED) technique or by intra-carotid injection. "
12/01/2011 - "Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect."
01/01/2015 - "The greater effect of the Fc-diOH-LNC-loaded MIAMI cells may be accounted for by their peritumoral distribution and a longer residence time of the drug within the tumor. "
01/01/2015 - "In this study, we used a subpopulation of human mesenchymal stem cells, "marrow-isolated adult multilineage inducible" (MIAMI) cells, which have endogenous tumor-homing activity, to deliver LNCs containing an organometallic complex (ferrociphenol or Fc-diOH), in the orthotopic U87MG GB model. "
09/11/2009 - "Ferrociphenol (Fc-diOH) is a new molecule belonging to the fast-growing family of organometallic anti-cancer drugs. "
|4.||Brain Neoplasms (Brain Tumor)
02/14/2012 - "Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy."
02/14/2012 - "In this study, we assessed whether the cytotoxic effects of MIAMI cells loaded with LNCs containing an organometallic complex (ferrociphenol or Fc-diOH) could be used to treat brain tumors. "
|5.||Breast Neoplasms (Breast Cancer)
09/10/2008 - "Ferrocenyl diphenol tamoxifen derivative (Fc-diOH) is one of the most active molecules of a new class of organometallic drugs, showing in vitro antiproliferative effects on both hormone-dependent and independent breast cancer cells. "
01/22/2008 - "For the first time, two organometallic triphenylethylene compounds (Fc-diOH and DFO), with strong antiproliferative activity in breast cancer cells, but insoluble in biological fluids, were incorporated in two types of stealth nanoparticles (NP): PEG/PLA nanospheres (NS) and nanocapsules (NC). "
|6.||monomethoxypolyethyleneglycol- polylactide block copolymer
|3.||Heterologous Transplantation (Xenotransplantation)